[Response and remission in depressive patients with anxiety symptoms treated with venlafaxine extended release in primary care].
- Published Article
Actas españolas de psiquiatría
- Publication Date
Jan 01, 2006
In this study, venlafaxine extended release shows that it is an effective and safe drug in the treatment of the depressive-anxious symptoms of patients with depressive syndrome treated in primary care, both in remission and response rates. It would be of interest to compare data of venlafaxine extended release with that of other antidepressive drugs, such as SSRI.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/16736389